ebola
viru
ebov
member
famili
filovirida
envelop
negativestrand
rna
virus
associ
highli
lethal
diseas
fdaapprov
vaccin
treatment
exist
filoviru
particl
character
threadlik
morpholog
infecti
virion
averag
nm
length
nm
diamet
viral
genom
encapsid
sever
protein
nucleoprotein
np
form
ribonucleocapsid
along
l
polymeras
matrix
protein
add
structur
support
interfac
nucleocapsid
viral
envelop
stud
viral
membran
metast
trimer
glycoprotein
gp
spike
compos
disulfidelink
heterodim
receptorbind
subunit
fusion
subunit
filoviru
subunit
categor
class
viral
fusion
protein
basi
major
domain
heptad
repeat
hr
region
ntermin
hr
compris
segment
encircl
along
intern
fusion
loop
pack
adjac
monom
insert
appos
host
membran
fusion
loop
must
extric
posit
prefus
spike
presum
extend
refold
postfus
structur
trimer
mark
sixhelix
bundl
format
consist
class
viral
fusion
protein
bring
host
viral
membran
close
proxim
lower
kinet
barrier
fusion
hemifus
outer
bilay
leaflet
preced
format
full
fusion
pore
cytoplasm
releas
viral
genom
like
filovirus
ebov
capabl
bind
varieti
surfac
molecul
contribut
broad
cellular
tropism
ctype
lectin
phosphatidylserin
receptor
implic
attach
though
role
uptak
fulli
defin
tcell
immunoglobulin
may
act
receptor
epitheli
cell
intern
ebov
occur
primarili
macropinocytosislik
process
viru
traffic
endocyt
pathway
proteolyt
cleavag
class
lowphactiv
proteas
cystein
cathepsin
remov
ctermin
glycan
cap
mucin
domain
sequenc
reveal
receptorbind
domain
newli
expos
domain
interact
niemannpick
serv
oblig
intracellular
receptor
filovirus
cathepsin
cleavag
subsequ
bind
indispens
infect
insuffici
mediat
releas
viral
genom
cytoplasm
final
trigger
fusion
viral
endosom
membran
postul
demonstr
precis
endosom
compart
actual
support
fusion
unknown
date
progress
defin
requir
ebov
fusion
trigger
hamper
lack
robust
assay
true
biolog
relev
order
examin
gp
trigger
fulli
use
realtim
microscopi
assay
detect
gpmediat
lipid
mix
within
cell
assay
enabl
event
gp
trigger
lipid
mix
uncoupl
full
fusion
infect
report
character
gpmediat
lipid
mix
investig
host
factor
thought
involv
process
find
identifi
essenti
distinct
role
cystein
cathepsin
ebov
gp
fusion
trigger
evalu
ebov
gp
trigger
biosafeti
level
condit
gener
vesicular
stomat
viru
vsv
pseudotyp
provid
highli
valid
surrog
system
recapitul
filoviru
entri
facilit
viral
track
experi
virion
engin
contain
fluoresc
protein
monomer
neongreen
mng
fuse
viral
phosphoprotein
p
heavili
glycosyl
mucin
domain
muc
ebov
gp
dispens
entri
delet
enhanc
viral
attach
accordingli
primarili
use
vsv
pseudotyp
bear
mucin
domaindelet
gp
valid
viral
prepar
label
vsv
bear
mngp
ebov
bound
coverslip
incub
alexa
fluor
neutral
antibodi
recogn
conform
epitop
interfac
averag
didlabel
particl
also
possess
ngp
signal
total
particl
exhibit
triplelabel
indic
prepar
use
high
qualiti
fig
lipophil
dye
spontan
incorpor
membran
display
fluoresc
selfquench
high
concentr
lipid
mix
viral
host
bilay
hemifus
fusion
enabl
later
diffus
dye
accompani
dequench
increas
fluoresc
intens
virion
label
fluoresc
signal
selfquench
detect
prior
dequench
dequench
result
sharp
increas
signal
defin
least
doubl
intens
within
net
increas
intens
within
min
typic
observ
fig
c
see
also
movi
supplement
materi
experi
increas
signal
sort
strictli
one
two
group
fast
slow
fast
dequench
indic
repres
trace
fig
solid
line
occur
irrespect
nucleocapsid
releas
data
shown
appear
indic
specif
trigger
lipid
mix
event
attribut
significantli
lower
rate
dequench
fig
dot
line
nonspecif
transfer
dye
host
membran
possibl
particl
degrad
fast
event
constitut
dequench
studi
found
extent
dequench
vari
somewhat
among
didlabel
particl
may
reflect
differ
volum
endocyt
compart
well
concentr
dye
within
viral
membran
heterogen
selfquench
note
dequench
event
occur
later
postinfect
time
point
gener
exhibit
greater
amplitud
quench
dequench
state
data
shown
initi
investig
dequench
kinet
vero
cell
due
high
permiss
establish
use
filoviru
infect
studi
time
span
need
particl
bear
ebov
dequench
min
consider
greater
min
similar
particl
bear
vsv
g
believ
undergo
fusion
trigger
earli
endosom
fig
found
dequench
kinet
vsvebov
particl
similar
cell
min
fig
autofluoresc
much
lower
vero
cell
use
cell
bulk
experi
regardless
cell
type
virtual
dequench
event
occur
within
h
synchron
onset
infect
also
examin
dequench
kinet
vsv
particl
bear
fulllength
ebov
gp
although
onset
conclus
dequench
event
show
similar
time
overal
rate
dequench
vsvebov
gp
min
slower
vsvebov
may
reflect
differ
intern
need
addit
proteolyt
process
fig
precleavag
ebov
thermolysin
structur
function
mimic
requir
cleavag
ebov
gp
endosomallysosom
cystein
proteas
cathepsin
b
acceler
dequench
kinet
compar
uncleav
ebov
live
imag
reveal
major
virion
engag
lipid
mix
fig
total
number
cellassoci
vsvebov
particl
approxim
dequench
vero
cell
cell
within
h
addit
particl
bear
fulllength
ebov
gp
dequench
cell
time
span
vsv
g
particl
show
similarli
low
probabl
lipid
mix
two
cell
type
although
unabl
distinguish
definit
bound
intern
virion
nearli
cellassoci
particl
traffick
perinuclear
region
end
experi
data
shown
lead
us
believ
uptak
level
high
ebov
gp
vsv
g
low
percentag
particl
actual
relev
infect
valid
singleparticl
approach
elucid
aspect
ebov
entri
order
confirm
observ
dequench
event
inde
repres
gpmediat
lipid
mix
first
assess
dequench
presenc
failur
acidifi
endosom
preclud
gp
activ
infect
low
ph
requir
cystein
cathepsin
activ
possibl
fusogen
conform
chang
gp
found
nearli
complet
reduct
vsvebov
dequench
treatment
lend
support
observ
lipid
mix
specif
gp
mediat
fig
need
host
cystein
cathepsin
cleavag
ebov
gp
infect
well
establish
pancystein
cathepsin
inhibitor
prevent
entri
filovirus
differ
prefer
cleavag
cathepsin
b
l
found
treatment
reduc
ebov
lipid
mix
lipid
mix
vsv
gbear
particl
similarli
affect
fig
demonstr
lack
cystein
cathepsin
activ
hinder
downstream
event
lipid
mix
ebov
gp
neutral
antibodi
direct
ebov
gp
base
zmapp
antibodi
cocktail
hypothes
inhibit
fusogen
structur
rearrang
evalu
effect
lipid
mix
fig
result
confirm
zmapp
treatment
specif
render
ebov
gp
less
abl
engag
lipid
mix
leav
viral
intern
traffick
unalt
see
fig
supplement
materi
preincub
vsvebov
result
inhibit
dequench
zmapp
also
concentrationdepend
slightli
potent
effect
dequench
lipid
mix
inhibit
neither
antibodi
treatment
abl
abolish
dequench
even
though
concentr
use
approxim
higher
report
valu
viral
neutral
individu
support
idea
exist
signific
barrier
fusion
number
unencumb
gp
molecul
need
simpl
lipid
mix
much
lower
number
need
bring
membran
fusion
genom
releas
collect
result
signifi
lipid
mix
express
product
gp
trigger
entail
degre
conform
chang
proteolyt
prime
ebov
gp
may
lead
encompass
full
fusion
endosomallysosom
membran
protein
involv
cholesterol
homeostasi
serv
essenti
intracellular
receptor
filoviru
infect
cystein
cathepsincleav
form
gp
directli
recogn
lumen
domain
c
precis
role
filoviru
entri
fulli
defin
evalu
lipid
mix
absenc
see
fig
supplement
materi
dequench
vsvebov
particl
inhibit
almost
entir
cell
wherea
vsv
g
dequench
unaffect
indic
express
vital
ebov
fusion
trigger
fig
mutat
put
interfac
previous
demonstr
reduc
interact
greatli
impair
infect
recent
work
shown
proteolyt
cleavag
expos
site
compris
basicpolar
crest
overhang
deep
hydrophob
trough
investig
entri
vsvebov
particl
bear
three
mutat
site
trough
crest
abolish
interact
viral
infect
lipid
mix
reduc
tripl
mutant
fig
inhibit
lipid
mix
vsvebov
gp
cell
vsvebov
gp
wildtyp
wt
cell
explain
alter
deliveri
endosomallysosom
compart
sinc
postinfect
coloc
viral
particl
endocyt
marker
significantli
reduc
see
fig
supplement
materi
function
cholesterol
transport
may
also
bear
ebov
entri
gpmediat
lipid
mix
select
inhibit
cation
amphiphil
fig
induc
diseas
phenotyp
mark
cholesterol
accumul
within
late
endosom
lysosom
bind
affect
shortterm
treatment
caus
substanti
cholesterol
accumul
see
fig
supplement
materi
nevertheless
prevent
ebov
entri
suggest
block
due
drug
specif
effect
rather
result
increas
endosomallysosom
cholesterol
level
taken
togeth
result
provid
direct
evid
facilit
one
earli
step
ebov
membran
fusion
coloc
dequench
virion
fluoresc
label
endosom
marker
perform
order
elucid
compart
ebov
gpdepend
membran
fusion
trigger
fig
see
also
movi
supplement
materi
although
recent
report
suggest
ebov
fuse
exclus
compart
devoid
found
dequench
particl
cell
coloc
marker
time
dequench
fig
see
also
movi
addit
high
percentag
dequench
particl
coloc
green
fluoresc
protein
gfp
indic
ubiqu
protein
endosom
support
gp
trigger
evid
ebov
must
traffic
suitabl
matur
compart
fusion
provid
inhibit
dequench
twopor
calcium
channel
tpc
block
small
molecul
tetrandrin
fig
tetrandrin
may
impair
activ
tpc
endocyt
traffick
heterotyp
fusion
vesicl
recent
shown
inhibit
ebov
infect
vitro
vivo
decreas
gpmediat
lipid
mix
assay
consider
lipid
mix
also
occur
vesicl
found
surprisingli
signific
fraction
dequench
vsvebov
particl
coloc
puncta
despit
slower
rate
lipid
mix
event
fig
particl
bear
fulllength
ebov
gp
also
dequench
compart
data
shown
appear
nearli
essenti
compon
ebov
fusion
compart
vesicl
like
intermedi
endosom
suggest
gp
trigger
occur
earlier
endocyt
pathway
commonli
believ
result
also
impli
popul
endosom
must
display
concurr
least
cell
line
use
detect
averag
lag
min
rang
min
coloc
viral
signal
dequench
indic
occurr
gp
trigger
immedi
upon
deliveri
compart
fig
examin
effect
fusion
loop
mutat
lipid
mix
test
two
previous
publish
mutant
fig
intern
late
endosom
deliveri
vsv
particl
bear
mutant
differ
significantli
vsvebov
see
fig
supplement
materi
indic
defect
specif
aspect
fusion
gp
mutant
character
impair
membran
bind
insert
capabl
exhibit
defect
lipid
mix
unabl
support
infect
anoth
fusion
loop
mutant
gp
show
substanti
decreas
lipid
mix
mutat
believ
prevent
format
hydrophob
fusion
loop
tip
low
ph
creat
scaffold
along
nonviabl
doubl
mutant
effect
lowlevel
lipid
mix
fig
suggest
even
sever
disrupt
gp
fusion
loop
retain
capac
membran
insert
cell
order
separ
possibl
requir
cystein
cathepsin
pre
bind
evalu
lipid
mix
gp
variou
cleavag
state
presenc
absenc
thermolysin
use
gener
particl
either
fulli
partial
lack
ctermin
sequenc
correspond
glycan
cap
mucin
domain
fig
increas
infect
particl
bear
cleav
gp
report
observ
phenomenon
enhanc
lipid
mix
particl
bound
cell
extent
cleav
uncleav
gp
produc
similar
level
lipid
mix
infect
fig
c
unexpectedli
found
dequench
particl
cleav
ebov
gp
much
less
suscept
blockag
degre
lipid
mix
correl
extent
gp
cleavag
fig
fulli
cleav
gp
exhibit
slight
hyperfusogen
unaffect
absenc
cathepsin
activ
inabl
precleavag
rescu
infect
cell
fig
howev
indic
specif
requir
cathepsin
fusion
pore
format
lie
bind
previou
attempt
character
ebov
membran
fusion
reli
assess
deliveri
viral
content
luciferas
gp
trigger
infer
content
deliveri
assay
use
character
infect
gener
scale
sizabl
limit
exampl
resolv
fate
individu
particl
differenti
hemifus
incomplet
fusion
pore
expans
gp
trigger
order
examin
gp
fusion
trigger
directli
employ
assay
track
realtim
lipid
mix
singl
particl
reveal
novel
signific
aspect
process
found
unsurprisingli
major
cellassoci
particl
advanc
lipid
mix
fig
low
probabl
lipid
mix
suggest
result
previous
publish
experi
util
bulk
endocytosi
may
mislead
inadvert
focu
nontrigg
virion
present
particular
obstacl
determin
factor
involv
ebov
gp
fusion
trigger
compart
trigger
occur
interact
cystein
cathepsinprim
previous
shown
vital
filoviru
infect
howev
precis
role
process
unknown
use
cell
line
gp
mutant
unabl
bind
prove
interact
coloc
indispens
ebov
fusion
trigger
lipid
mix
fig
found
appear
virusbear
endosom
alway
preced
gp
trigger
though
time
span
two
event
vari
fig
also
report
simmon
colleagu
livecel
imag
assay
gppseudotyp
retrovirus
current
articl
prepar
mingo
et
al
propos
deliveri
vesicl
repres
key
ratelimit
step
ebov
fusion
found
lag
rang
min
coloc
dequench
unknown
present
whether
bind
directli
promot
fusogen
conform
chang
gp
prime
interact
addit
host
factor
therefor
lag
may
repres
span
time
need
viru
bind
lumen
domain
appear
compart
may
also
signifi
need
one
host
factor
act
gp
prior
follow
interact
provid
direct
evid
ebov
gp
fusion
trigger
occur
vesicl
may
fact
encompass
rang
endosom
compart
previous
thought
undergo
trigger
quit
late
endocyt
pathway
ebov
gp
could
mediat
lipid
mix
intermedi
endosom
indic
signal
live
assay
presenc
absolut
requir
dequench
assay
infer
popul
vesicl
must
contain
cell
coloc
imposs
immunofluoresc
fraction
studi
shown
local
primarili
entir
late
endosom
lysosom
transgolgi
network
therefor
level
intermedi
endosom
may
suffici
support
gp
trigger
howev
unclear
whether
viral
genom
releas
rel
immatur
endosom
occur
follow
gp
fusion
trigger
inde
simmon
et
al
found
evid
gpmediat
retrovir
content
releas
compart
rais
possibl
virion
must
traffic
endocyt
pathway
encount
host
factor
level
necessari
complet
fusion
genom
releas
previou
work
reveal
conform
epitop
interfac
gp
base
target
multipl
neutral
antibodi
includ
two
three
compon
zmapp
therapeut
cocktail
lead
hypothesi
epitop
achil
heel
filovirus
propos
structur
ground
basebind
antibodi
potent
neutral
block
fusogen
rearrang
membran
insert
provid
first
direct
evid
neutral
antibodi
target
ebov
gp
base
inhibit
viral
fusion
trigger
fig
interestingli
higher
concentr
neutral
antibodi
requir
inhibit
lipid
mix
extent
infect
may
typifi
fusion
envelop
virus
recent
studi
otterstrom
et
al
examin
level
antibodi
bind
need
inhibit
influenza
viru
hemifus
use
pair
potent
broadli
effect
neutral
antibodi
whose
inhibitori
profil
influenza
viru
strain
similar
zmapp
filovirus
author
show
high
concentr
stembind
antibodi
abl
block
major
hemifus
event
although
assay
viral
particl
bound
support
bilay
differ
data
strongli
corrobor
result
approxim
either
antiinfluenza
viru
antibodi
need
reduc
vitro
hemifus
requir
antibodi
concentr
beyond
relev
infect
indic
far
lower
threshold
lipid
mix
full
fusion
content
releas
highlight
distinct
ebov
lipid
mix
fusion
found
gp
mutat
abrog
infect
necessarili
extend
lipid
mix
fig
although
mutat
shown
reduc
bind
ectodomain
liposom
note
lipid
mix
live
cell
unaffect
addit
peptid
correspond
fusion
loop
gp
mutant
unabl
insert
model
membran
promot
lipid
mix
cellfre
system
likewis
found
doubl
mutant
could
support
infect
lipid
mix
activ
within
cell
significantli
reduc
complet
inhibit
indic
amino
acid
sequenc
may
behav
differ
nativ
gp
isol
peptid
much
less
vitro
system
shallow
insert
fusion
loop
may
suffici
yield
lipid
mix
cell
even
fail
interact
target
membran
extens
enough
progress
full
fusion
pore
format
entri
virion
bear
precleav
ebov
gp
remain
sensit
inhibitor
host
cystein
cathepsin
activ
suggest
exist
addit
proteasedepend
step
filoviru
membran
fusion
surprisingli
howev
experi
reveal
lipid
mix
cleav
gp
entir
unaffect
inhibit
host
cystein
cathepsin
activ
even
infect
ablat
report
previous
fig
latter
find
agreement
simmon
et
al
found
evid
content
releas
retrovir
particl
bear
cleav
gp
cell
howev
unabl
examin
lipid
mix
consist
assay
find
suggest
follow
bind
cystein
cathepsin
dispens
gp
fusion
trigger
lipid
mix
play
critic
role
format
andor
expans
fusion
pore
allow
cytoplasm
releas
viral
genom
advanc
two
mechanist
scenario
account
observ
first
fusion
trigger
compris
possibl
addit
signal
eg
acid
ph
cystein
cathepsin
releas
gp
prefus
conform
allow
format
membranebound
prehairpin
intermedi
drive
hemifus
viral
cellular
membran
final
cystein
cathepsin
cleavag
event
enabl
gp
refold
mediat
fusion
pore
format
genom
releas
similar
twostep
mechan
sequenti
role
receptor
bind
low
ph
propos
fusion
avian
sarcomaleukosi
retroviru
altern
conceiv
proteolyt
cleavag
gp
inde
fusion
trigger
gp
fusion
trigger
format
nevertheless
occur
ineffici
absenc
cystein
cathepsin
activ
rearrang
gp
trimer
may
permit
lipid
mix
energet
costli
fusion
pore
format
expans
initi
studi
focus
primarili
gp
trigger
lipid
mix
step
ebov
entri
work
need
elucid
outstand
issu
precis
mechan
explain
cathepsin
activ
requir
infect
lipid
mix
futur
livecel
studi
examin
dynam
fusion
pore
expans
viral
genom
releas
provid
comprehens
understand
ebov
entri
process
human
osteosarcoma
cell
cultur
mccoy
medium
gibco
vero
grivet
monkey
kidney
cell
human
embryon
kidney
cell
cultur
dulbecco
modifi
eagl
medium
gibco
cultur
media
supplement
fetal
bovin
serum
fb
uml
penicillin
streptomycin
gener
cell
carri
genom
edit
use
previous
describ
method
briefli
crispr
guid
rna
grna
clone
vector
addgen
plasmid
encod
grna
target
nucleotid
ggccttgtcattacttgaggggg
complementari
strand
human
mrna
cotransfect
along
plasmid
encod
humancodonoptim
endonucleas
addgen
plasmid
red
fluoresc
protein
express
plasmid
monitor
transfect
effici
pmxiresbla
confer
blasticidin
resist
transfect
cell
follow
select
transfect
cell
blasticidin
treatment
genom
dna
flank
grna
target
site
amplifi
pcr
use
forward
tcataaacacaccaaacttggaatc
revers
tcctgcggcagaggttttc
primer
test
indel
surveyor
assay
previous
describ
genom
edit
confirm
popul
level
multipl
singlecel
clone
isol
gene
sequenc
clonal
cell
line
found
contain
delet
nucleotid
allel
delet
cell
predict
caus
frame
shift
amino
acid
posit
lead
product
truncat
protein
amino
acid
comparison
amino
acid
wildtyp
confirm
absenc
remain
wildtyp
allel
revers
transcriptionpcr
rtpcr
use
aggccccctcaagtaatgac
specif
delet
sequenc
cell
line
gcccaaagtgctggtcaaag
primer
amplif
proteas
gene
use
gatgtgctctggcagatggg
tttcacgccagaaccccgc
primer
use
posit
control
rtpcr
pseudotyp
virion
gener
infect
cell
express
viral
glycoprotein
vsv
lack
g
gene
previous
describ
gp
cdna
deriv
ebov
mayinga
isol
use
gener
vsvebov
gp
ebov
lack
gp
residu
ebov
gp
mutant
gener
background
infect
supernat
collect
upon
observ
signific
cytopathi
day
postinfect
clarifi
supernat
centrifug
g
use
rotor
pellet
viru
viral
pellet
resuspend
phosphatebuff
salin
pb
purifi
sucros
cushion
g
use
rotor
pellet
resuspend
pb
approxim
viral
protein
concentr
mgml
aliquot
store
use
viral
infect
assess
previous
describ
cleavag
ebovgp
perform
incub
viru
thermolysin
sigma
h
partial
cleav
gp
thermolysin
h
fulli
cleav
gp
first
ultracentrifug
step
proteas
activ
quench
addit
mm
phosphoramidon
peptid
intern
incub
ice
min
prior
second
ultracentrifug
step
sucros
cushion
extent
cleavag
confirm
immunoblot
antibodi
viral
membran
label
selfquench
concentr
life
technolog
viru
incub
min
gentl
agit
dark
room
temperatur
label
viru
pass
column
ge
healthcar
remov
excess
dye
larg
aggreg
use
imag
within
h
label
reduc
viral
infect
less
data
shown
zmapp
gift
john
dye
usamriid
product
variou
heavi
lightchain
domain
chemic
synthes
codonoptim
sequenc
express
human
cell
epoch
life
scienc
clone
pmazigh
contain
express
cassett
human
chain
constant
domain
pmazigl
contain
express
cassett
human
lightchain
constant
domain
vector
respect
use
gibson
assembl
kit
new
england
biolab
sanger
sequenc
confirm
ident
clone
vector
antibodi
product
purif
carri
describ
earlier
modif
briefli
suspensionadapt
suspens
cultur
freestyl
express
media
thermo
scientif
cotransfect
ratio
vector
use
polyethyleneimin
day
posttransfect
supernat
collect
incub
overnight
protein
agaros
resin
genscript
corpor
presenc
complet
mini
edtafre
proteas
inhibitor
cocktail
roch
life
scienc
resin
wash
pb
ph
bound
igg
elut
mm
glycin
ph
trishcl
ph
eluat
concentr
buffer
exchang
pb
use
amicon
centrifug
filter
concentr
millipor
molecular
weight
cutoff
da
purifi
antibodi
store
protein
concentr
yield
determin
uv
absorb
puriti
determin
sdspage
label
coverslipbound
viru
conjug
zenon
alexa
fluor
life
technolog
accord
manufactur
instruct
stock
solut
drug
prepar
dimethyl
sulfoxid
dmso
water
store
frozen
aliquot
use
cell
incub
ammonium
chlorid
sigma
min
peptid
intern
tetrandrin
sigma
h
prior
experi
perform
indic
concentr
preincub
calbiochem
perform
inhibitor
maintain
concentr
spinocul
imag
express
fluoresc
label
endocyt
pathway
marker
cell
transduc
celllight
vector
life
technolog
earli
endosom
late
endosom
lysosom
h
prior
imag
accord
manufactur
instruct
retrovir
packag
vector
bear
also
gener
cell
transduc
h
advanc
imag
live
imag
perform
deltavis
widefield
epifluoresc
microscop
ge
healthcar
microscop
equip
heat
environment
chamber
electronmultipli
chargecoupl
devic
emccd
camera
photometr
numericalapertur
na
oil
immers
object
dapi
fluorescein
isothiocyan
fitc
tetramethyl
rhodamin
isocyan
tritc
filter
set
cell
seed
fibronectinco
coverslip
dish
mattek
h
advanc
experi
grown
approxim
confluenc
dish
place
ice
sever
minut
addit
viru
viru
imag
buffer
mm
nacl
mm
kcl
mm
mm
mm
hepe
mm
glucos
hoechst
stain
fb
ph
spinocul
onto
cell
min
centrifug
g
inoculum
volum
adjust
cellassoci
particl
visibl
per
field
unbound
particl
remov
four
wash
cold
pb
cold
imag
buffer
ad
dish
sampl
mount
microscop
quickli
focus
ml
warm
imag
buffer
ad
start
experi
imag
acquir
everi
durat
experi
use
singl
zsection
cell
flat
exclud
initi
kinet
studi
experi
limit
h
imag
analysi
singleparticl
track
perform
use
voloc
softwar
perkinelm
exclud
minor
adjust
bright
contrast
imag
file
manipul
singleparticl
dequench
measur
puncta
threshold
initi
intens
size
puncta
fall
outsid
rang
expect
discret
vsv
particl
exclud
analysi
coloc
dequench
particl
cellular
marker
virion
consid
coloc
gfp
mng
punctum
exceed
cellular
background
signal
gfp
mng
puncta
cotraffick
greater
overlap
signal
gfp
mng
signal
least
dequench
event
major
coloc
dequench
event
far
exceed
criteria
mean
measur
standard
deviat
sd
deriv
three
separ
experi
unless
otherwis
indic
statist
signific
establish
student
test
oneway
analysi
varianc
anova
post
hoc
dunnett
test
p
p
p
